The antitumor action of cannabinoids on glioma tumorigenesis

• Panagiotis Zogopoulo ^[1] ; Penelope Korkolopoulou ^[1] ; Efstratios Patsouris ^[1] ; Stamatios Theocharis ^[1]
  1. [1] University of Athens
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 30, Nº. 6, 2015, págs. 629-645
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Cannabinoids are a class of chemical compounds with a wide spectrum of pharmacological effects, mediated by two specific plasma membrane receptors (CB1 and CB2). Recently, CB1 and CB2 expression levels have been detected in human tumors, including those of brain. Cannabinoids-endocannabinoids exert anti-inflammatory, anti-proliferative, anti-invasive, anti-metastatic and pro-apoptotic effects in different cancer types, both in vitro and in vivo in animal models, after local or systemic administration. We present the available experimental and clinical data, to date, regarding the antitumor action of cannabinoids on the tumorigenesis of gliomas.